HOME >> BIOLOGY >> NEWS
Underserved US minorities face 'unequal burden of cancer' that must be corrected

Barriers to healthy lifestyles, early detection services and good medical care are contributing to higher cancer incidence and mortality rates for African Americans and other medically underserved minorities in this country, when compared with white U.S. citizens.

As a result, the War on Cancer declared about three decades ago by President Nixon -- cannot be won until this "unequal burden of cancer" is corrected, according to reports by a panel of cancer clinicians and public health officials in the March issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research (AACR).

"In our efforts to reduce disparities, we must identify and remove all of the barriers that prevent the benefits of research from reaching all of the people," wrote Harold P. Freeman, M.D., director of the Ralph Lauren Center for Cancer Care and Prevention in New York City and director of the Center to Reduce Cancer Health Disparities at the National Cancer Institute.

"These barriers are a major cause of health disparities," he added. "This is a national issue, a policy issue." Added Frederick P. Li, M.D., of the Dana-Farber Cancer Institute in Boston who assembled the panel for an October 2001: "The burden of cancer is not equally distributed within the U.S. population, but differs by race, ethnicity and, other demographic characteristics."

"Clearly, it is essential that we address this disparity and work to ensure that all Americans have equal access and quality cancer care."

Statistics tell part of the story, particularly for African Americans:

African Americans are 30 percent more likely to die from cancer than white Americans. In 2003, an estimated 132,700 new cancers will be diagnosed among African Americans and 63,100 deaths will be recorded. In 1992-1999, overall age-adjusted U.S. incidence rates for all cancers combined (per 1 million population) were 527 for African Americans and 480 fo
'"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
25-Mar-2003


Page: 1 2 3 4

Related biology news :

1. White House lauds Physiological Society for mentoring underrepresented minorities in biomedicine
2. Study: overweight more common among early-maturing girls, especially minorities
3. Improved nutrition could reduce malaria burden worldwide
4. Obesity in Costa Rican children alarming, likely future health burden
5. Studies offer data on potential impact of Reminyl on caregiver burden in Alzheimers disease
6. Scientists find drastic underestimations of malaria morbidity, mortality, and economic burden
7. Environmental health burdens of poor Asian, Native American, African American and Hispanic communities featured at special session of Soc. of Tox.
8. Distinctive genetic program guides breast cancers deadly spread
9. Scientists find protein that controls prostate cancers spread
10. U-M scientists find cancers genetic core: 67 genes universally activated in human cancer
11. U-M scientists reveal prostate cancers molecular fingerprint. Study links proteins to patient prognosis.

Post Your Comments:
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 16, 2015  In recognition of World Hemophilia Day, ... groups to illuminate more than 15 prominent landmarks red throughout ... Boston,s Zakim Bridge and Prudential Tower, ... Mercedes-Benz Superdome and Denver,s ... of April 17, and coincide with hemophilia community events in ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: